AI-generated summary
The authors studied whether low-level laser therapy enhances peripheral endogenous opioid analgesia, using a rat model of inflammation and Jurkat human T-cell leukemia cells. They report that laser treatment produced analgesia in inflamed tissue that was transiently reversed by naloxone, and that beta-endorphin precursor mRNA expression increased both in vivo and in vitro. The findings are presented as suggesting an additional mechanism for laser-induced analgesia in rats.
- Who or what was studied
- Rats with peripheral inflammation and Jurkat human T-cell leukemia cells (in vitro)
- Limits stated in the abstract
- The study used a rat model and a cell line in vitro, so the findings may not translate directly to humans, and the abstract does not report sample sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.